↓ Skip to main content

Arthropod venom Hyaluronidases: biochemical properties and potential applications in medicine and biotechnology

Overview of attention for article published in Journal of Venomous Animals and Toxins including Tropical Diseases, October 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
148 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Arthropod venom Hyaluronidases: biochemical properties and potential applications in medicine and biotechnology
Published in
Journal of Venomous Animals and Toxins including Tropical Diseases, October 2015
DOI 10.1186/s40409-015-0042-7
Pubmed ID
Authors

Karla C F Bordon, Gisele A. Wiezel, Fernanda G. Amorim, Eliane C. Arantes

Abstract

Hyaluronidases are enzymes that mainly degrade hyaluronan, the major glycosaminoglycan of the interstitial matrix. They are involved in several pathological and physiological activities including fertilization, wound healing, embryogenesis, angiogenesis, diffusion of toxins and drugs, metastasis, pneumonia, sepsis, bacteremia, meningitis, inflammation and allergy, among others. Hyaluronidases are widely distributed in nature and the enzymes from mammalian spermatozoa, lysosomes and animal venoms belong to the subclass EC 3.2.1.35. To date, only five three-dimensional structures for arthropod venom hyaluronidases (Apis mellifera and Vespula vulgaris) were determined. Additionally, there are four molecular models for hyaluronidases from Mesobuthus martensii, Polybia paulista and Tityus serrulatus venoms. These enzymes are employed as adjuvants to increase the absorption and dispersion of other drugs and have been used in various off-label clinical conditions to reduce tissue edema. Moreover, a PEGylated form of a recombinant human hyaluronidase is currently under clinical trials for the treatment of metastatic pancreatic cancer. This review focuses on the arthropod venom hyaluronidases and provides an overview of their biochemical properties, role in the envenoming, structure/activity relationship, and potential medical and biotechnological applications.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Turkey 1 <1%
Switzerland 1 <1%
Unknown 146 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 17%
Student > Bachelor 24 16%
Student > Ph. D. Student 14 9%
Researcher 10 7%
Student > Postgraduate 10 7%
Other 24 16%
Unknown 41 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 39 26%
Agricultural and Biological Sciences 25 17%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Chemistry 6 4%
Medicine and Dentistry 5 3%
Other 12 8%
Unknown 52 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2016.
All research outputs
#16,061,963
of 25,394,764 outputs
Outputs from Journal of Venomous Animals and Toxins including Tropical Diseases
#282
of 539 outputs
Outputs of similar age
#156,966
of 294,310 outputs
Outputs of similar age from Journal of Venomous Animals and Toxins including Tropical Diseases
#9
of 16 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 539 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 294,310 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.